Cargando…

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease

BACKGROUND: Despite substantial research and development investment in Alzheimer’s disease (AD), effective therapeutics remain elusive. Significant emerging evidence has linked cholesterol, β-amyloid and AD, and several studies have shown a reduced risk for AD and dementia in populations treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geifman, Nophar, Brinton, Roberta Diaz, Kennedy, Richard E., Schneider, Lon S., Butte, Atul J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316146/ https://www.ncbi.nlm.nih.gov/pubmed/28212683 http://dx.doi.org/10.1186/s13195-017-0237-y

Ejemplares similares

Data-driven identification of endophenotypes of Alzheimer’s disease progression: implications for clinical trials and therapeutic interventions
por: Geifman, Nophar, et al.
Publicado: (2018)

Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases
por: Torrandell‐Haro, Georgina, et al.
Publicado: (2020)

Sex and APOE genotype differences related to statin use in the aging population
por: Dagliati, Arianna, et al.
Publicado: (2021)

Opening clinical trial data: are the voluntary data-sharing portals enough?
por: Geifman, Nophar, et al.
Publicado: (2015)

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis
por: Kennedy, Richard E., et al.
Publicado: (2018)

Towards an Age-Phenome Knowledge-base
por: Geifman, Nophar, et al.
Publicado: (2011)

The age-phenome database
por: Geifman, Nophar, et al.
Publicado: (2012)

The Mouse Age Phenome Knowledgebase and Disease-Specific Inter-Species Age Mapping
por: Geifman, Nophar, et al.
Publicado: (2013)

Association of combination statin and antihypertensive therapy with reduced Alzheimer’s disease and related dementia risk
por: Barthold, Douglas, et al.
Publicado: (2020)

A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases
por: Geifman, Nophar, et al.
Publicado: (2020)

The effect of statins on rate of cognitive decline in mild cognitive impairment
por: Smith, Kyle B., et al.
Publicado: (2017)

The Neural/Immune Gene Ontology: clipping the Gene Ontology for neurological and immunological systems
por: Geifman, Nophar, et al.
Publicado: (2010)

New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing
por: Zador, Zsolt, et al.
Publicado: (2018)

Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment
por: Wang, Guoqiao, et al.
Publicado: (2015)

Associations of specific-age and decade recall body mass index trajectories with obesity-related cancer
por: Watson, Charlotte, et al.
Publicado: (2021)

Identifying developments over a decade in the digital health and telemedicine landscape in the UK using quantitative text mining
por: Geifman, Nophar, et al.
Publicado: (2023)

The Cognitive Effects of Statins are Modified by Age
por: Alsehli, Ahmed M., et al.
Publicado: (2020)

Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change?
por: Kennedy, Richard E., et al.
Publicado: (2015)

Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase
por: Geifman, Nophar, et al.
Publicado: (2014)

Clinical trial data reuse – overcoming complexities in trial design and data sharing
por: Wilkinson, Toby, et al.
Publicado: (2019)

The challenges in data integration – heterogeneity and complexity in clinical trials and patient registries of Systemic Lupus Erythematosus
por: Le Sueur, Helen, et al.
Publicado: (2020)

Early Decline in Glucose Transport and Metabolism Precedes Shift to Ketogenic System in Female Aging and Alzheimer's Mouse Brain: Implication for Bioenergetic Intervention
por: Ding, Fan, et al.
Publicado: (2013)

What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?
por: Murphy, Claire, et al.
Publicado: (2023)

Composite cognitive and functional measures for early stage Alzheimer's disease trials
por: Schneider, Lon S., et al.
Publicado: (2020)

Rates of Cognitive Decline in 100 Patients With Alzheimer Disease
por: Miyakawa-Liu, Monica, et al.
Publicado: (2022)

A polymorphism in HLA-G modifies statin benefit in asthma
por: Naidoo, Devesh, et al.
Publicado: (2014)

Multimorbidity states associated with higher mortality rates in organ dysfunction and sepsis: a data-driven analysis in critical care
por: Zador, Zsolt, et al.
Publicado: (2019)

Hospitalization, Alzheimer's Disease and Related Neuropathologies, and Cognitive Decline
por: James, Bryan D., et al.
Publicado: (2019)

Periodontitis and Cognitive Decline in Alzheimer’s Disease
por: Ide, Mark, et al.
Publicado: (2016)

Reversal of cognitive decline in Alzheimer's disease
por: Bredesen, Dale E., et al.
Publicado: (2016)

Cognitive Decline: Not Always Alzheimer’s Disease
por: Villalba, Noel Lorenzo, et al.
Publicado: (2018)

Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer’s Disease
por: Murchison, Charles F., et al.
Publicado: (2022)

CHILD: a new tool for detecting low-abundance insertions and deletions in standard sequence traces
por: Zhidkov, Ilia, et al.
Publicado: (2011)

Integrated Multi-Omics Analyses in Oncology: A Review of Machine Learning Methods and Tools
por: Nicora, Giovanna, et al.
Publicado: (2020)

Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease
por: Whetton, Anthony D., et al.
Publicado: (2020)

A patient-level data meta-analysis of standard-of-care treatments from eight prostate cancer clinical trials
por: Geifman, N., et al.
Publicado: (2016)

Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer’s disease
por: Kumar, Atul, et al.
Publicado: (2021)

Response to peer commentaries: Composite cognitive and functional measures for early stage Alzheimer's disease trials
por: Schneider, Lon S., et al.
Publicado: (2020)

Statins and cognition: Modifying factors and possible underlying mechanisms
por: Jamshidnejad-Tosaramandani, Tahereh, et al.
Publicado: (2022)

Cognitive Declines Precede and Predict Functional Declines in Aging and Alzheimer’s Disease
por: Zahodne, Laura B., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g51j7lv6mi1rqga8c5n4lhbgv2